扶桑薬品工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2014/08/01 | 日証協 | 127,558株 | +6.69% | 21,000株 | +44.67% | 194,342株 | +1.57% | 19,164株 | +139.55% |
| 2014/07/25 | 日証協 | 119,558株 | +9.13% | 14,516株 | -34.02% | 191,342株 | -25.36% | 8,000株 | +33.33% |
| 2014/07/18 | 日証協 | 109,558株 | +5.79% | 22,000株 | +10% | 256,342株 | 0% | 6,000株 | -93.63% |
| 2014/07/11 | 日証協 | 103,558株 | +9.71% | 20,000株 | +33.33% | 256,341株 | +51.52% | 94,165株 | +841.65% |
| 2014/07/04 | 日証協 | 94,394株 | +5.59% | 15,000株 | +650% | 169,177株 | -0.59% | 10,000株 | 0% |
| 2014/06/27 | 日証協 | 89,394株 | +2.29% | 2,000株 | -60% | 170,177株 | -3.41% | 0株 | -100% |
| 2014/06/20 | 日証協 | 87,394株 | 0% | 5,000株 | 0% | 176,177株 | -1.67% | 56,000株 | +818.03% |
| 2014/06/13 | 日証協 | 87,394株 | +1.16% | 0株 | -100% | 179,177株 | +2.28% | 6,100株 | +510% |
| 2014/06/06 | 日証協 | 86,394株 | -3.36% | 3,000株 | 0% | 175,177株 | -7.4% | 1,000株 | -50% |
| 2014/05/30 | 日証協 | 89,394株 | -2.19% | 3,000株 | -66.67% | 189,177株 | +7.38% | 2,000株 | -88.24% |
| 2014/05/23 | 日証協 | 91,394株 | +3.39% | 9,000株 | +273.29% | 176,177株 | +0.57% | 17,000株 | -54.46% |
| 2014/05/16 | 日証協 | 88,394株 | +0.47% | 2,411株 | +141.1% | 175,177株 | +18.49% | 37,331株 | +366.64% |
| 2014/05/09 | 日証協 | 87,983株 | 0% | 1,000株 | -96.75% | 147,846株 | -3.9% | 8,000株 | +700% |
| 2014/05/02 | 日証協 | 87,983株 | 0% | 30,758株 | 0% | 153,846株 | -8.34% | 1,000株 | -66.67% |
| 2014/04/25 | 日証協 | 87,983株 | 0% | 0株 | -100% | 167,846株 | +4.35% | 3,000株 | -57.14% |
| 2014/04/18 | 日証協 | 87,983株 | -0.46% | 3,589株 | -10.28% | 160,846株 | -7.7% | 7,000株 | -89.71% |
| 2014/04/11 | 日証協 | 88,394株 | -5.77% | 4,000株 | +873.24% | 174,257株 | -3.86% | 68,000株 | +116.42% |
| 2014/04/04 | 日証協 | 93,805株 | -1.67% | 411株 | 0% | 181,258株 | +23.44% | 31,421株 | +14.6% |
| 2014/03/28 | 日証協 | 95,394株 | +33.62% | 0株 | 0% | 146,837株 | +31.3% | 27,417株 | +61.28% |
※株式分割は考慮していませんのでご注意ください。